| [1] |
Ma H, Wu L, Duan J, et al. SERPINC1 novel mutation (c. 637C> T p. Gln213Ter) in a cerebral venous sinus thrombosis case and treatment with agatroban[J]. Thrombosis Research，2021，199：35-37.
|
| [2] |
Abbattista M, Gianniello F, Novembrino C, et al. Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study [J]. The Lancet Haematology，2020，7(4)：e320-e328.
|
| [3] |
van Dijk MM, Kolte AM, Limpens J, et al. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis[J]. Human Reproduction Update，2020，26(3)：356-367.
|
| [4] |
James AH, Bates SM, Bauer KA, et al. Management of hereditary antithrombin deficiency in pregnancy[J]. Thrombosis Research，2017，157：41-45.
|
| [5] |
胡丽丽，彭萍，刘欣燕，等. 家系中抗凝血酶Ⅲ缺乏症致反复妊娠丢失二例分析[J]. 中华妇产科杂志，2018，53(2)：118-120.
|
| [6] |
James AH, Rhee E, Thames B, et al. Characterization of antithrombin levels in pregnancy[J]. Thrombosis Research，2014，134(3)：648-651.
|
| [7] |
卢秋敏，刘宇茵，贺芳. 妊娠合并遗传性抗凝血酶Ⅲ缺陷症1例[J]. 中华妇产科杂志，2022，57(3)：224-226.
|
| [8] |
中华医学会血液学分会血栓与止血学组. 易栓症诊断与防治中国指南(2021年版)[J]. 中华血液学杂志，2021，42(11)：881-888.
|
| [9] |
American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy[J]. Obstet Gynecol，2018，132(1)：e18-e34.
|
| [10] |
Queensland Health. Queensland Clinical Guidelines. Venous thromboembolism (VTE) in prophylaxis in pregnancy and the puerperium clinical guideline education presentation E20.9-1-V4-R25.2020.[EB/OL]．(2020)[2022-09-13]．
URL
|
| [11] |
Royal College of Obstetricians and Gynaecologists. Thromboembolic disease in pregnancy and the puerperium：acute management(Green-top Guideline No. 37b)[EB/OL]．(2015-04)[2022-09-13].
URL
|
| [12] |
Cohen H, Efthymiou M, Devreese KMJ. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome [J]. Journal of Thrombosis and Haemostasis，2021，19(4)：892-908.
|
| [13] |
Levy JH, Connors JM. Heparin resistance—clinical perspectives and management strategies[J]. New England Journal of Medicine，2021，385(9)：826-832.
|
| [14] |
Kovac M. Antithrombin deficiency in pregnancy—The unresolved issues[J]. The Lancet Haematology，2020，7(4)：e276-e278.
|
| [15] |
Bramham K, Retter A, Robinson SE, et al. How I treat heterozygous hereditary antithrombin deficiency in pregnancy [J]. Thrombosis and Haemostasis，2013，110(9)：550-559.
|
| [16] |
Bauer KA, Nguyen-Cao TM, Spears JB. Issues in the diagnosis and management of hereditary antithrombin deficiency [J]. Annals of Pharmacotherapy，2016，50(9)：758-767.
|
| [17] |
Pabinger I, Thaler J. How I treat patients with hereditary antithrombin deficiency [J]. Blood，2019，134(26)：2346-2353.
|
| [18] |
Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis[J]. Interactive Cardiovascular and Thoracic Surgery，2014，18(6)：797-806.
|
| [19] |
中华医学会心血管病学分会，中国老年学学会心脑血管病专业委员会. 华法林抗凝治疗的中国专家共识[J]. 中华内科杂志，2013，52(1)：76-82.
|
| [20] |
Zhang X, Guo F, Wang Q, et al. Management of heparin resistance due to antithrombin deficiency in a Chinese pregnant woman: a case report[J]. Journal of International Medical Research，2021，49(11)：1-7.
|
| [21] |
Zhao L, Bi S, Fu J, et al. Retrospective analysis of fondaparinux and low-molecular-weight heparin in the treatment of women with recurrent spontaneous abortion[J]. Frontiers in Endocrinology，2021，12：1-6.
|
| [22] |
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC)[J]. European Heart Journal，2018，39(34)：3165-3241.
|
| [23] |
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest，2008，133(6)：381S-453S.
|
| [24] |
Committee on Obstetric Practice Society for Maternal-Fetal Medicine. ACOG Committee Opinion No. 743. Low-dose aspirin use during pregnancy[J]. Obstet Gynecol，2018，132(1)：e44-e52.
|
| [25] |
Hoffman M K, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial[J]. The Lancet，2020，395(10220)：285-293.
|